For instance, in renal cell carcinoma (Zhang et al., 2022), bladder cancer (Tao et al., 2021), breast cancer (Xu et al., 2020) and leukemia (Li et al., 2017), FTO functions as a tumor promoting factor. The gene discussed is FTO; the disease is neoplasm.